Morphometric and dynamic studies of bone changes in hyperthyroidism
- PMID: 848285
- DOI: 10.1089/ten.2005.11.1034
Morphometric and dynamic studies of bone changes in hyperthyroidism
Abstract
Bone biopsies were performed after tetracycline double-labelling by transfixing the right iliac crest in forty hyperthyroid patients. The bone changes in cortical and trabecular bone were determined by simple measurement and point counting on decalcified and undecalcified stained sections. A slight decrease in the amount of cancellous bone was found. The mean cortical width was normal. The amount of osteoid and the length of the osteoid seams were increased, whereas the mean width of osteoid seams was decreased. The cortical osteoclastic activity and porosity were markedly increased. The trabecular osteoclasic activity was moderately increased and the mean size of periosteocytic lacunae was slightly increased. The calcification rate in cancellous bone was increased as were the active calcification surfaces (tetracycline-labelled). The osteoclastic activity in cortical bone was positively correlated to the free thyroxine index and to the urinary calcium and phosphorus excretion. The findings indicate that the bone changes in hyperthyroidism are specific and that thyroid hormone(s) stimulates both bone formation and resorption followed by increased porosity in cortical bone and by mobilization of bone mineral.
Similar articles
-
Morphometric and dynamic studies of bone changes in hypothyroidism.Acta Pathol Microbiol Scand A. 1978 Jan;86(1):56-62. doi: 10.1111/j.1699-0463.1978.tb02012.x. Acta Pathol Microbiol Scand A. 1978. PMID: 636889
-
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism.Acta Endocrinol (Copenh). 1977 Jul;85(3):515-25. doi: 10.1530/acta.0.0850515. Acta Endocrinol (Copenh). 1977. PMID: 577336
-
Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry.Acta Endocrinol (Copenh). 1978 Apr;87(4):751-8. doi: 10.1530/acta.0.0870751. Acta Endocrinol (Copenh). 1978. PMID: 580521
-
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.APMIS Suppl. 2001;(102):1-52. APMIS Suppl. 2001. PMID: 11419022 Review.
-
Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.APMIS Suppl. 1995;51:1-44. APMIS Suppl. 1995. PMID: 7669370 Review.
Cited by
-
Lack of α2C-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia.PLoS One. 2016 Jan 27;11(1):e0146795. doi: 10.1371/journal.pone.0146795. eCollection 2016. PLoS One. 2016. PMID: 26815679 Free PMC article.
-
Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.J Thyroid Res. 2015;2015:796871. doi: 10.1155/2015/796871. Epub 2015 Jul 13. J Thyroid Res. 2015. PMID: 26246934 Free PMC article.
-
Bone turnover in hyperthyroidism before and after thyrostatic management.J Endocrinol Invest. 2000 Dec;23(11):727-31. doi: 10.1007/BF03345061. J Endocrinol Invest. 2000. PMID: 11194705
-
Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.J Endocrinol Invest. 1995 Apr;18(4):277-82. doi: 10.1007/BF03347813. J Endocrinol Invest. 1995. PMID: 7560809
-
The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.Calcif Tissue Int. 1993 Oct;53(4):278-82. doi: 10.1007/BF01320914. Calcif Tissue Int. 1993. PMID: 8275357
MeSH terms
Substances
LinkOut - more resources
Full Text Sources